MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11547-025-02069-w

Медицинская библиотека · La Radiologia medica · 2025

Conventional vs. DEB vs. DSM: Which technique for palliative TACE in intermediate-stage HCC? Results on 70 patients in terms of efficacy and tolerance.

Giurazza Francesco, Carrubba Claudio, Punzi Ernesto, Tortora Raffaella, Guarracino Marco, Brangi Fiorella, Falaschi Federica, Migliaccio Carla, Corvino Fabio, Vennarecci Giovanni, Di Costanzo Giuseppe Giovanni, Lombardi Giulio, Niola Raffaella

Клиническое исследованиеСравнительное исследованиеСтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

PURPOSE: This study aims to compare palliative cTACE, DEB-TACE and DSM-TACE in patients affected by HCC in intermediate BCLC stage in terms of efficacy and patient tolerance.

MATERIALS AND

METHODS

Patients treated with palliative TACE were prospectively enrolled in two centers during 9 months. Procedures were performed superselectively in all patients. Inclusion criteria were: HCC diagnosis, intermediate BCLC stage, portal tree patency, preserved hepatic-renal-coagulation functions, palliative procedural aim, follow-up available up to 6-month post-TACE intervention. Exclusion criteria were: previous TACE treatments, alone or in combination with ablation in the same session, ascites, bilirubin > 2mg/dL, age < 18years, bridge to transplant procedural aim, concomitant infectious diseases. Primary endpoint was to compare efficacy and patients tolerance among the 3 different TACE techniques; secondary endpoint was to compare post-procedural complications occurrence.

RESULTS

Seventy patients were included and divided into three groups according to the TACE technique: 24 were treated with cTACE, 25 with DEB-TACE, 21 with DSM-TACE. According to mRECIST criteria at 1-, 3- and 6-month follow-up, DEB-TACE presented better local response rates but without statistically significant differences. Patients treated with DSM-TACE showed significantly better tolerance, considering post-procedural transaminases and INR values together with clinical adverse events occurrence monitored up to 7 days. There were no differences in post-procedural complications and no major complications occurred.

CONCLUSIONS

In this study, in patients with intermediate-stage HCC undergoing palliative treatments, no significant differences emerged comparing cTACE, DEB-TACE and DSM-TACE in terms of procedural efficacy; however, patients treated with DSM-TACE showed significant better procedural tolerance.

Для цитирования: Giurazza Francesco, Carrubba Claudio, Punzi Ernesto, Tortora Raffaella, Guarracino Marco, Brangi Fiorella, Falaschi Federica, Migliaccio Carla, Corvino Fabio, Vennarecci Giovanni, Di Costanzo Giuseppe Giovanni, Lombardi Giulio, Niola Raffaella. Conventional vs. DEB vs. DSM: Which technique for palliative TACE in intermediate-stage HCC? Results on 70 patients in terms of efficacy and tolerance.. La Radiologia medica. 2025. DOI: 10.1007/s11547-025-02069-w.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.